Home » Authors » Mark Lawson

Articles by Mark Lawson

Peptech Suffers On Uncertainty Of Royalties For TNF Product

Feb. 26, 2003

SIRTeX Officials Welcome Idea Of $161M Acquisition By Cephalon

Feb. 19, 2003

SIRTeX Officials Welcome Idea Of $161M Acquisition By Cephalon

Feb. 19, 2003

Australian Stock Gains Could Signal A Turnaround In Sector

Jan. 29, 2003

Australian Stock Gains Could Signal A Turnaround In Sector

Jan. 29, 2003

Peptech Raises A$10M, Gets Boost By Approval Of Humira

Jan. 15, 2003

Peptech Raises A$10M, Gets Boost By Approval Of Humira

Jan. 15, 2003

BresaGen Licenses Patent Rights Related To Stem Cell Programs

Nov. 27, 2002

BresaGen Licenses Patent Rights Related To Stem Cell Programs

Nov. 27, 2002

Peptech Stock Declines Following News of Centocor Royalty Dispute

Nov. 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...